glp 1 vs semaglutide vs tirzepatide GLP-1 for Weight Loss in Adults Semaglutide vs Tirzepatide: 2026 Comparison

Qsymia is approved for chronic weight management, unlike phentermine monotherapy which has only short-term approval

Yet, there are others turning to a cheaper alternative: compounded semaglutide

Beyond cardiovascular sequelae, MASLD/MASH is independently associated with an increased risk of chronic kidney disease (CKD), likely via overlapping mechanisms involving systemic inflammation, altered adipokine profiles, and activation of the renin-angiotensin system 8

Individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN2) should discuss this with their clinician before considering any GLP-1based therapy, and should be alert to symptoms such as a neck lump, hoarseness, or difficulty swallowing